Cooperation Invitation | Frost & Sullivan is about to release the '2026 China Healthcare Digital Marketing White Paper'.

As medical and health services become more online and artificial intelligence applications continue to deepen, digital marketing is expanding from content dissemination and product reach into professional education, consultative decision-making, drug purchase fulfillment, and ongoing health management. How to respond to the health needs of diverse audiences with credible professional content and connect them to subsequent services is an issue of common concern for medical and health enterprises and digital platforms.

Based on its ongoing research into China’s medical and health industry and digital practices, Frost & Sullivan (hereafter referred to as "Frost & Sullivan") is about to release the '2026 China Medical and Health Digital Marketing White Paper'. The white paper analyzes industry drivers, compliant marketing and AI applications, category-specific marketing practices, platform ecosystem, and future trends, providing industry reference for medical and health enterprises, digital platforms, and related industry participants.

The white paper begins with the changes in health needs, the development of digital technology, and the evolution of industry service models, outlining the background and application value of medical and health digital marketing, analyzing academic dissemination targeting professionals such as doctors and pharmacists, as well as popular science education and service reach needs for patients and health consumers.

Focusing on five key aspects—information collection, content creation, compliance review, content distribution, and trust and conversion—the white paper compares traditional operations with AI-assisted applications, exploring the connection between need identification, evidence-based content production, layered dissemination, intelligent consultation, and ongoing services, and highlighting the role of professional review, content basis, and process management in these areas.

At the application level, the white paper focuses on innovative drugs, over-the-counter drugs (OTC), medical devices, elderly health, nutrition and tonic products, analyzing the characteristics of different categories in market launch education, scenario reach, professional trust, usage guidance, and long-term operation, and discussing the accumulation of standardized operational capabilities and cross-category reuse.

Regarding the platform ecosystem and future trends, the white paper outlines the functional divisions of professional academic platforms, patient and consumer service platforms, and full-chain platforms, and, in conjunction with representative practices, analyzes the coordination between professional content, consulting services, payment assurance, and transaction fulfillment, and evaluates the development directions brought about by intelligent agent applications, innovative payment assurance, and policy pilot programs.

Frost & Sullivan sincerely invites pharmaceutical and medical device companies, nutritional health brands, digital healthcare platforms, and related technical service institutions to engage in exchanges, exploring specialized research, professional content dissemination, and consulting cooperation around industry-related issues of common concern.

Leveraging its ongoing industry research, engaging in discussions on niche markets, user needs, and platform ecosystem, the white paper provides a reference for business planning for enterprises.

Combined with the disease areas, product categories, or technical applications of the enterprise’s focus, the white paper explores specialized research, case analysis, and professional content cooperation.

Focusing on topics such as market entry, brand communication, and growth strategy, the white paper explores more targeted research and consulting cooperation.

If you wish to engage in cooperation such as industry research, special reports, professional content dissemination, or strategic consulting regarding medical and health digital marketing, please contact Frost & Sullivan. We look forward to exploring future cooperation opportunities in conjunction with your business needs and industry practices—whether you are from a pharmaceutical and medical device company, a nutritional health brand, a digital healthcare and pharmaceutical e-commerce platform, or from the fields of medical人工智能, digital marketing, and related technical service institutions. We look forward to exploring more cooperation opportunities in conjunction with your business needs and professional practices.

Please scan the QR code below to leave your contact information and cooperation intentions; we will contact you at the earliest opportunity.